Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122172) titled 'Effects of Ramulus Mori (Sangzhi) Alkaloids Tablets on Body Composition, Visceral Fat, and Related Metabolic Parameters in Patients with Type 2 Diabetes Mellitus' on April 9.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Hunan University of Medicine General Hospital
Condition:
Type 2 diabetes mellitus
Intervention:
Ramulus Mori (Sangzhi) alkaloids (SZ-A) group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-09
Target Sample Size: Ramulus Mori (Sangzhi) alkaloids (SZ-A) group:100;Acarbose group:100;
Countries of Recruitment:
China
T...